{"count":221304,"next":"https://panelapp-aus.org/api/v1/activities/?format=json&page=1694","previous":"https://panelapp-aus.org/api/v1/activities/?format=json&page=1692","results":[{"created":"2020-08-02T14:45:11.488505+10:00","panel_name":"Arthrogryposis","panel_id":47,"panel_version":"0.196","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: TOR1A: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Arthrogryposis multiplex congenita, MIM#618947; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"TOR1A","entity_type":"gene"},{"created":"2020-08-02T13:26:17.942261+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.3633","user_name":"Zornitza Stark","item_type":"entity","text":"Tag disputed tag was added to gene: SYNE2.","entity_name":"SYNE2","entity_type":"gene"},{"created":"2020-08-01T21:49:48.761722+10:00","panel_name":"Arthrogryposis","panel_id":47,"panel_version":"0.195","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MED12 as ready","entity_name":"MED12","entity_type":"gene"},{"created":"2020-08-01T21:49:48.741351+10:00","panel_name":"Arthrogryposis","panel_id":47,"panel_version":"0.195","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: med12 has been classified as Green List (High Evidence).","entity_name":"MED12","entity_type":"gene"},{"created":"2020-08-01T21:49:42.365142+10:00","panel_name":"Arthrogryposis","panel_id":47,"panel_version":"0.195","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: MED12 were changed from  to MED12-related disorders","entity_name":"MED12","entity_type":"gene"},{"created":"2020-08-01T21:49:12.883620+10:00","panel_name":"Arthrogryposis","panel_id":47,"panel_version":"0.194","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: MED12 were set to ","entity_name":"MED12","entity_type":"gene"},{"created":"2020-08-01T21:48:48.552601+10:00","panel_name":"Arthrogryposis","panel_id":47,"panel_version":"0.193","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: MED12 was changed from Unknown to X-LINKED: hemizygous mutation in males, biallelic mutations in females","entity_name":"MED12","entity_type":"gene"},{"created":"2020-08-01T21:47:36.707016+10:00","panel_name":"Arthrogryposis","panel_id":47,"panel_version":"0.192","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: TRIP4 as ready","entity_name":"TRIP4","entity_type":"gene"},{"created":"2020-08-01T21:47:36.698723+10:00","panel_name":"Arthrogryposis","panel_id":47,"panel_version":"0.192","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: trip4 has been classified as Green List (High Evidence).","entity_name":"TRIP4","entity_type":"gene"},{"created":"2020-08-01T21:47:34.008934+10:00","panel_name":"Arthrogryposis","panel_id":47,"panel_version":"0.192","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: TRIP4 were changed from  to Spinal muscular atrophy with congenital bone fractures 1, MIM# 616866","entity_name":"TRIP4","entity_type":"gene"},{"created":"2020-08-01T21:47:06.796294+10:00","panel_name":"Arthrogryposis","panel_id":47,"panel_version":"0.191","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: TRIP4 were set to ","entity_name":"TRIP4","entity_type":"gene"},{"created":"2020-08-01T21:46:44.357263+10:00","panel_name":"Arthrogryposis","panel_id":47,"panel_version":"0.190","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: TRIP4 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"TRIP4","entity_type":"gene"},{"created":"2020-08-01T18:44:32.965149+10:00","panel_name":"Alagille syndrome","panel_id":36,"panel_version":"0.5","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: NOTCH2 as ready","entity_name":"NOTCH2","entity_type":"gene"},{"created":"2020-08-01T18:44:32.954705+10:00","panel_name":"Alagille syndrome","panel_id":36,"panel_version":"0.5","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: notch2 has been classified as Green List (High Evidence).","entity_name":"NOTCH2","entity_type":"gene"},{"created":"2020-08-01T18:44:30.117963+10:00","panel_name":"Alagille syndrome","panel_id":36,"panel_version":"0.5","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: NOTCH2 were changed from  to Alagille syndrome 2, MIM# 610205","entity_name":"NOTCH2","entity_type":"gene"},{"created":"2020-08-01T18:44:01.957727+10:00","panel_name":"Alagille syndrome","panel_id":36,"panel_version":"0.4","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: NOTCH2: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Alagille syndrome 2, MIM# 610205; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"NOTCH2","entity_type":"gene"},{"created":"2020-08-01T18:43:36.398094+10:00","panel_name":"Alagille syndrome","panel_id":36,"panel_version":"0.4","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: JAG1 as ready","entity_name":"JAG1","entity_type":"gene"},{"created":"2020-08-01T18:43:36.389975+10:00","panel_name":"Alagille syndrome","panel_id":36,"panel_version":"0.4","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: jag1 has been classified as Green List (High Evidence).","entity_name":"JAG1","entity_type":"gene"},{"created":"2020-08-01T18:43:34.168976+10:00","panel_name":"Alagille syndrome","panel_id":36,"panel_version":"0.4","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: JAG1 were changed from  to Alagille syndrome, MIM# 1 118450","entity_name":"JAG1","entity_type":"gene"},{"created":"2020-08-01T18:43:06.378216+10:00","panel_name":"Alagille syndrome","panel_id":36,"panel_version":"0.3","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: JAG1: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Alagille syndrome, MIM# 1 118450; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"JAG1","entity_type":"gene"},{"created":"2020-08-01T18:42:02.041336+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.82","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: SDHD as ready","entity_name":"SDHD","entity_type":"gene"},{"created":"2020-08-01T18:42:02.023664+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.82","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: sdhd has been classified as Green List (High Evidence).","entity_name":"SDHD","entity_type":"gene"},{"created":"2020-08-01T18:41:55.447666+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.82","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: SDHD were changed from  to Paragangliomas 1, with or without deafness, MIM# 168000; Pheochromocytoma, MIM# 171300","entity_name":"SDHD","entity_type":"gene"},{"created":"2020-08-01T18:41:28.808561+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.81","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: SDHD was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"SDHD","entity_type":"gene"},{"created":"2020-08-01T18:40:58.449301+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.80","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: SDHD: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Paragangliomas 1, with or without deafness, MIM# 168000, Pheochromocytoma, MIM# 171300; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"SDHD","entity_type":"gene"},{"created":"2020-08-01T18:40:04.236779+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.80","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: SDHC as ready","entity_name":"SDHC","entity_type":"gene"},{"created":"2020-08-01T18:40:04.227638+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.80","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: sdhc has been classified as Green List (High Evidence).","entity_name":"SDHC","entity_type":"gene"},{"created":"2020-08-01T18:39:58.562802+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.80","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: SDHC were changed from  to Paragangliomas 3, MIM# 605373","entity_name":"SDHC","entity_type":"gene"},{"created":"2020-08-01T18:39:33.611652+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.79","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: SDHC was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"SDHC","entity_type":"gene"},{"created":"2020-08-01T18:39:07.211140+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.78","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: SDHC: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Paragangliomas 3, MIM# 605373; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"SDHC","entity_type":"gene"},{"created":"2020-08-01T18:38:36.144610+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.78","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: SDHB as ready","entity_name":"SDHB","entity_type":"gene"},{"created":"2020-08-01T18:38:36.136343+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.78","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: sdhb has been classified as Green List (High Evidence).","entity_name":"SDHB","entity_type":"gene"},{"created":"2020-08-01T18:38:33.853554+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.78","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: SDHB were changed from  to Paragangliomas 4, MIM# 115310","entity_name":"SDHB","entity_type":"gene"},{"created":"2020-08-01T18:38:08.502770+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.77","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: SDHB was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"SDHB","entity_type":"gene"},{"created":"2020-08-01T18:37:46.450262+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.76","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: SDHB: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Paragangliomas 4, MIM# 115310; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"SDHB","entity_type":"gene"},{"created":"2020-08-01T18:37:09.289862+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.76","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: SDHAF2 as ready","entity_name":"SDHAF2","entity_type":"gene"},{"created":"2020-08-01T18:37:09.278422+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.76","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: sdhaf2 has been classified as Green List (High Evidence).","entity_name":"SDHAF2","entity_type":"gene"},{"created":"2020-08-01T18:36:58.161190+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.76","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: SDHAF2 were changed from  to Paragangliomas 2, MIM# 601650","entity_name":"SDHAF2","entity_type":"gene"},{"created":"2020-08-01T18:36:37.553389+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.75","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: SDHAF2 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"SDHAF2","entity_type":"gene"},{"created":"2020-08-01T18:36:14.351619+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.74","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: SDHAF2: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Paragangliomas 2, MIM# 601650; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"SDHAF2","entity_type":"gene"},{"created":"2020-08-01T18:23:21.294900+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.74","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: SDHA as ready","entity_name":"SDHA","entity_type":"gene"},{"created":"2020-08-01T18:23:21.282544+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.74","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: sdha has been classified as Green List (High Evidence).","entity_name":"SDHA","entity_type":"gene"},{"created":"2020-08-01T18:23:18.862024+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.74","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: SDHA were changed from  to Paragangliomas 5, MIM# 614165","entity_name":"SDHA","entity_type":"gene"},{"created":"2020-08-01T18:23:02.769927+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.73","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: SDHA was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"SDHA","entity_type":"gene"},{"created":"2020-08-01T18:22:36.167894+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.72","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: SDHA: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Paragangliomas 5, MIM# 614165; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"SDHA","entity_type":"gene"},{"created":"2020-08-01T18:21:33.925339+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.72","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: RUNX1 as ready","entity_name":"RUNX1","entity_type":"gene"},{"created":"2020-08-01T18:21:33.916304+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.72","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: runx1 has been classified as Green List (High Evidence).","entity_name":"RUNX1","entity_type":"gene"},{"created":"2020-08-01T18:21:31.416332+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.72","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: RUNX1 were changed from  to Leukemia, acute myeloid, MIM# 601626","entity_name":"RUNX1","entity_type":"gene"},{"created":"2020-08-01T18:21:02.827371+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.71","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: RUNX1 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"RUNX1","entity_type":"gene"},{"created":"2020-08-01T18:20:40.393729+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.70","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: RUNX1: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Leukemia, acute myeloid, MIM# 601626; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"RUNX1","entity_type":"gene"},{"created":"2020-08-01T18:20:00.605483+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.70","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: TRIP13 as ready","entity_name":"TRIP13","entity_type":"gene"},{"created":"2020-08-01T18:20:00.596704+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.70","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: trip13 has been classified as Green List (High Evidence).","entity_name":"TRIP13","entity_type":"gene"},{"created":"2020-08-01T18:19:58.403210+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.70","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: TRIP13 were changed from  to Mosaic variegated aneuploidy syndrome 3, MIM# 617598","entity_name":"TRIP13","entity_type":"gene"},{"created":"2020-08-01T18:19:39.050909+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.69","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: TRIP13 were set to ","entity_name":"TRIP13","entity_type":"gene"},{"created":"2020-08-01T18:19:14.889319+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.68","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: TRIP13 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"TRIP13","entity_type":"gene"},{"created":"2020-08-01T18:18:48.344679+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.67","user_name":"Zornitza Stark","item_type":"entity","text":"edited their review of gene: TRIP13: Changed rating: GREEN","entity_name":"TRIP13","entity_type":"gene"},{"created":"2020-08-01T18:18:42.547644+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.67","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: TRIP13: Rating: ; Mode of pathogenicity: None; Publications: 28553959; Phenotypes: Mosaic variegated aneuploidy syndrome 3, MIM# 617598; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"TRIP13","entity_type":"gene"},{"created":"2020-08-01T18:16:18.163319+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.67","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: TMEM127 as ready","entity_name":"TMEM127","entity_type":"gene"},{"created":"2020-08-01T18:16:18.153995+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.67","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: tmem127 has been classified as Red List (Low Evidence).","entity_name":"TMEM127","entity_type":"gene"},{"created":"2020-08-01T18:16:16.112167+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.67","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: TMEM127 were changed from  to {Pheochromocytoma, susceptibility to}, MIM# 171300","entity_name":"TMEM127","entity_type":"gene"},{"created":"2020-08-01T18:16:00.042702+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.66","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: TMEM127 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"TMEM127","entity_type":"gene"},{"created":"2020-08-01T18:15:35.945675+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.65","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: TMEM127 as Red List (low evidence)","entity_name":"TMEM127","entity_type":"gene"},{"created":"2020-08-01T18:15:35.937829+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.65","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: tmem127 has been classified as Red List (Low Evidence).","entity_name":"TMEM127","entity_type":"gene"},{"created":"2020-08-01T18:15:13.540605+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.64","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: TMEM127: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: {Pheochromocytoma, susceptibility to}, MIM# 171300; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"TMEM127","entity_type":"gene"},{"created":"2020-08-01T18:13:43.831043+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.64","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: RAD51C as Red List (low evidence)","entity_name":"RAD51C","entity_type":"gene"},{"created":"2020-08-01T18:13:43.820493+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.64","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: rad51c has been classified as Red List (Low Evidence).","entity_name":"RAD51C","entity_type":"gene"},{"created":"2020-08-01T18:13:18.625273+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.63","user_name":"Zornitza Stark","item_type":"entity","text":"changed review comment from: Two families reported, paediatric tumour risk to be established.; to: Two families reported with congenital anomalies only, paediatric tumour risk to be established.","entity_name":"RAD51C","entity_type":"gene"},{"created":"2020-08-01T18:13:05.346133+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.63","user_name":"Zornitza Stark","item_type":"entity","text":"edited their review of gene: RAD51C: Changed rating: RED","entity_name":"RAD51C","entity_type":"gene"},{"created":"2020-08-01T18:12:12.404540+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.63","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: RAD51C as ready","entity_name":"RAD51C","entity_type":"gene"},{"created":"2020-08-01T18:12:12.393418+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.63","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: rad51c has been classified as Amber List (Moderate Evidence).","entity_name":"RAD51C","entity_type":"gene"},{"created":"2020-08-01T18:12:09.280453+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.63","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: RAD51C were changed from  to Fanconi anemia, complementation group O, MIM# 613390","entity_name":"RAD51C","entity_type":"gene"},{"created":"2020-08-01T18:11:41.066272+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.62","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: RAD51C were set to ","entity_name":"RAD51C","entity_type":"gene"},{"created":"2020-08-01T18:11:18.445012+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.61","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: RAD51C was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"RAD51C","entity_type":"gene"},{"created":"2020-08-01T18:10:54.064606+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.60","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: RAD51C as Amber List (moderate evidence)","entity_name":"RAD51C","entity_type":"gene"},{"created":"2020-08-01T18:10:54.049339+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.60","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: rad51c has been classified as Amber List (Moderate Evidence).","entity_name":"RAD51C","entity_type":"gene"},{"created":"2020-08-01T18:10:29.644850+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.59","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: RAD51C: Rating: AMBER; Mode of pathogenicity: None; Publications: 20400963, 29278735; Phenotypes: Fanconi anemia, complementation group O, MIM# 613390; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"RAD51C","entity_type":"gene"},{"created":"2020-08-01T18:06:19.859577+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.59","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MUTYH as ready","entity_name":"MUTYH","entity_type":"gene"},{"created":"2020-08-01T18:06:19.849332+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.59","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: mutyh has been classified as Red List (Low Evidence).","entity_name":"MUTYH","entity_type":"gene"},{"created":"2020-08-01T18:06:16.621169+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.59","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: MUTYH were changed from  to Adenomas, multiple colorectal, MIM# 608456","entity_name":"MUTYH","entity_type":"gene"},{"created":"2020-08-01T18:05:51.593026+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.58","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: MUTYH was changed from BIALLELIC, autosomal or pseudoautosomal to BIALLELIC, autosomal or pseudoautosomal","entity_name":"MUTYH","entity_type":"gene"},{"created":"2020-08-01T18:05:38.316327+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.58","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: MUTYH was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"MUTYH","entity_type":"gene"},{"created":"2020-08-01T18:05:15.443659+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.57","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: MUTYH as Red List (low evidence)","entity_name":"MUTYH","entity_type":"gene"},{"created":"2020-08-01T18:05:15.433166+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.57","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: mutyh has been classified as Red List (Low Evidence).","entity_name":"MUTYH","entity_type":"gene"},{"created":"2020-08-01T18:04:46.373319+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.56","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: MUTYH: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Adenomas, multiple colorectal, MIM# 608456; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"MUTYH","entity_type":"gene"},{"created":"2020-08-01T18:03:22.243013+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.56","user_name":"Zornitza Stark","item_type":"entity","text":"edited their review of gene: MAX: Changed rating: RED","entity_name":"MAX","entity_type":"gene"},{"created":"2020-08-01T18:03:13.577378+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.56","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MAX as ready","entity_name":"MAX","entity_type":"gene"},{"created":"2020-08-01T18:03:13.566089+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.56","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: max has been classified as Green List (High Evidence).","entity_name":"MAX","entity_type":"gene"},{"created":"2020-08-01T18:03:09.338501+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.56","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: MAX were changed from  to {Pheochromocytoma, susceptibility to}, MIM# 171300","entity_name":"MAX","entity_type":"gene"},{"created":"2020-08-01T18:02:48.528995+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.55","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: MAX were set to ","entity_name":"MAX","entity_type":"gene"},{"created":"2020-08-01T18:02:27.534856+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.54","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: MAX was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"MAX","entity_type":"gene"},{"created":"2020-08-01T18:01:52.840676+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.53","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: MAX: Rating: GREEN; Mode of pathogenicity: None; Publications: 21685915; Phenotypes: {Pheochromocytoma, susceptibility to}, MIM# 171300; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"MAX","entity_type":"gene"},{"created":"2020-08-01T17:59:23.955554+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.53","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: HRAS as ready","entity_name":"HRAS","entity_type":"gene"},{"created":"2020-08-01T17:59:23.944690+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.53","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: hras has been classified as Green List (High Evidence).","entity_name":"HRAS","entity_type":"gene"},{"created":"2020-08-01T17:58:57.474269+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.53","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: HRAS were changed from  to Costello syndrome, MIM# 218040","entity_name":"HRAS","entity_type":"gene"},{"created":"2020-08-01T17:58:40.152586+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.52","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: HRAS was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"HRAS","entity_type":"gene"},{"created":"2020-08-01T17:58:16.278624+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.51","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: HRAS: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Costello syndrome, MIM# 218040; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"HRAS","entity_type":"gene"},{"created":"2020-08-01T17:56:30.095341+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.51","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: GATA2 as ready","entity_name":"GATA2","entity_type":"gene"},{"created":"2020-08-01T17:56:30.086943+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.51","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: gata2 has been classified as Green List (High Evidence).","entity_name":"GATA2","entity_type":"gene"},{"created":"2020-08-01T17:56:26.567541+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.51","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: GATA2 were changed from  to {Leukemia, acute myeloid, susceptibility to}, MIM# 601626","entity_name":"GATA2","entity_type":"gene"},{"created":"2020-08-01T17:56:00.785464+10:00","panel_name":"Cancer Predisposition_Paediatric","panel_id":152,"panel_version":"0.50","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: GATA2 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"GATA2","entity_type":"gene"}]}